<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003745'>Sporadic</z:hpo> Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (sBL) can be delineated from diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) by a very homogeneous <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression signature </plain></SENT>
<SENT sid="1" pm="."><plain>However, it remained unclear whether <z:hpo ids='HP_0000001'>all</z:hpo> three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> variants-sBL, endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (eBL) and human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (HIV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>)-represent a uniform biological entity despite their differences in geographical occurrence, association with <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> and/or incidence of Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To address this issue, we generated micro <z:chebi fb="40" ids="33697">RNA</z:chebi> (miRNA) profiles from 18 eBL, 31 sBL and 15 HIV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cases </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, we analyzed the miRNA expression of 86 DLBCL to determine whether miRNA profiles recapitulate the molecular differences between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> evidenced by <z:chebi fb="2" ids="33699">mRNA</z:chebi> profiling </plain></SENT>
<SENT sid="4" pm="."><plain>A signature of 38 miRNAs containing MYC regulated and nuclear factor-kB pathway-associated miRNAs was obtained that differentiated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The miRNA profiles of sBL and eBL displayed only six differentially expressed miRNAs, whereas HIV and <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> had no impact on the miRNA profile of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, miRNA profiling confirms that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> represent distinct <z:hpo ids='HP_0002665'>lymphoma</z:hpo> categories and demonstrates that the three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> variants are representatives of the same biological entity with only marginal miRNA expression differences between eBL and sBL </plain></SENT>
</text></document>